フォロー
David M. Goldenberg
David M. Goldenberg
Founder and Emeritus Chairman of the Board, Immunomedics, Inc.
確認したメール アドレス: なし
タイトル
引用先
引用先
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning
DM Goldenberg, F DeLand, E Kim, S Bennett, FJ Primus, JR van Nagell Jr, ...
New England Journal of Medicine 298 (25), 1384-1388, 1978
10671978
Sacituzumab govitecan in metastatic triple-negative breast cancer
A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ...
New England journal of medicine 384 (16), 1529-1541, 2021
8632021
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
A Bardia, IA Mayer, LT Vahdat, SM Tolaney, SJ Isakoff, JR Diamond, ...
New England Journal of Medicine 380 (8), 741-751, 2019
7352019
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
DM Goldenberg
US Patent 6,306,393, 2001
5082001
Targeted therapy of cancer with radiolabeled antibodies
DM Goldenberg
Journal of Nuclear Medicine 43 (5), 693-713, 2002
4662002
A novel method of 18F radiolabeling for PET
WJ McBride, RM Sharkey, H Karacay, CA D'Souza, EA Rossi, ...
Journal of nuclear medicine 50 (6), 991-998, 2009
4522009
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
DM Goldenberg, RM Sharkey, G Paganelli, J Barbet, JF Chatal
Journal of Clinical Oncology 24 (5), 816, 2006
3992006
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen
DM Goldenberg, EE Kim, FH DeLand, S Bennett, FJ Primus
Cancer Research 40 (8_Part_2), 2984-2992, 1980
3901980
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
T Dörner, J Kaufmann, WA Wegener, N Teoh, DM Goldenberg, ...
Arthritis research & therapy 8, 1-11, 2006
3782006
Efficacy and safety of anti-trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer
A Bardia, IA Mayer, JR Diamond, RL Moroose, SJ Isakoff, AN Starodub, ...
Journal of Clinical Oncology 35 (19), 2141, 2017
3772017
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)
DM Goldenberg, TM Cardillo, SV Govindan, EA Rossi, RM Sharkey
Oncotarget 6 (26), 22496, 2015
3712015
Targeted therapy of cancer: new prospects for antibodies and immunoconjugates
RM Sharkey, DM Goldenberg
CA: a cancer journal for clinicians 56 (4), 226-243, 2006
3612006
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations
TM Behr, DM Goldenberg, W Becker
European journal of nuclear medicine 25, 201-212, 1998
3571998
Anti-CD20 antibodies and fusion proteins thereof and methods of use
H Hansen, Z Qu, DM Goldenberg
US Patent 7,151,164, 2006
3412006
Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections
DM Goldenberg, RM Sharkey, FJ Primus
Journal of the National Cancer Institute 57 (1), 11-22, 1976
3201976
Multivalent immunoglobulin-based bioactive assemblies
CH Chang, DM Goldenberg, EA Rossi
US Patent 7,527,787, 2009
3172009
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
SD Steinfeld, L Tant, GR Burmester, NKW Teoh, WA Wegener, ...
Arthritis research & therapy 8, 1-11, 2006
3162006
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
DM Goldenberg, JA Horowitz, RM Sharkey, TC Hall, S Murthy, ...
Journal of clinical oncology 9 (4), 548-564, 1991
3131991
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin’s lymphoma
JP Leonard, M Coleman, JC Ketas, A Chadburn, S Ely, RR Furman, ...
Journal of clinical oncology 21 (16), 3051-3059, 2003
3072003
Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G
DM Goldenberg, DF Preston, FJ Primus, HJ Hansen
Cancer Research 34 (1), 1-9, 1974
3041974
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20